Patents by Inventor Olin Liang

Olin Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240197775
    Abstract: Described herein are compositions and methods for the prevention or treatment of rheumatoid arthritis (RA). In some embodiments, RA is prevented or treated by (i) extracting peripheral blood mononuclear cells (PBMCs) and/or bone marrow mononuclear cells (BMMCs) from a subject at risk of, or afflicted with, RA; (ii) exposing the PBMCs/BMMCs to an effective amount of one or more SHIP-1 inhibitor and/or a pan-SHIP1/2 inhibitor to induce ex vivo expansion of the subject's myeloid derived suppressor cells (MDSCs); and (iii) administering intravenously to the subject a therapeutically effective number of MDSCs.
    Type: Application
    Filed: April 4, 2022
    Publication date: June 20, 2024
    Inventors: Olin Liang, Eui-Young So, Anthony Reginato
  • Publication number: 20230330089
    Abstract: A method of treating or preventing COVID-19 in a subject in need thereof is described. The method includes administering to the subject a therapeutically effective amount of an integrin inhibitor.
    Type: Application
    Filed: April 14, 2023
    Publication date: October 19, 2023
    Inventors: Wafik S. El-Deiry, Kelsey Huntington, Lindsey Carlsen, Olin Liang, Matthias Piesche